当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第16期
编号:2390778
单孔胸腔镜肺癌根治术在早期肺腺癌患者中的应用效果
http://www.100md.com 2025年8月9日 中国医学创新 2025年第16期
     Effect Single-port ThoracoscopicRadicalResectionLungCancer inPatientswithEarly Pulmonary Adenocarcinoma/LI Qizhong.//Medical Innovation China,2025,22(16): 005-009

    [Abstract]Objective:To analyze the influence single-port thoracoscopic radical resection lung cancer on complications,pain factors,prognosis,etc.inpatients with early pulmonary adenocarcinoma.Method:A total 6O patients with earlypulmonaryadenocarcinoma admited to Prefecturefrom January 2O22 to April 2O24 were selected and divided into the single-port groupandthe two-port group by simple randomization, with 3O cases in each group. Both groups underwent thoracoscopic radical resection lung cancer. The single-port group adopted the single-port method,and the two-port group adopted the two-port method. The surgery-related indicators,complications and prognosis [functional asessment cancer therapy-lung (FACT-L)], pain factors [neuropeptide Y (NPY), 5-hydroxytryptophan (5-HT),prostaglandin E2(PGE2) ] and pulmonary function indicators [forced expiratoryvolume inone second/forced vital capacity(FEV/FVC) ......

您现在查看是摘要页,全文长 13596 字符